7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics

7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics

Inhalational anaesthesia depends on the precise thermodynamic delivery of volatile liquids via vaporizers into a breathing circuit, their alveolar uptake into pulmonary capillary blood, and their distribution across the blood-brain barrier to central nervous system target sites. Mastering the physical principles, solubility coefficients, and kinetic wash-in equations allows anaesthetists to control the depth and speed of general anaesthesia with millimetric precision.

---

1. Physical and Thermodynamic Properties of Inhalational Anaesthetics

At standard ambient room temperature and sea-level atmospheric pressure (101.3 kPa / 760 mmHg), modern volatile agents exist in the liquid state, whereas nitrous oxide exists as a gas.

Definitions of Core Thermodynamic Parameters

• Saturated Vapour Pressure (SVP): The pressure exerted by the gas phase of a substance in dynamic equilibrium with its liquid phase within a closed container at a specified temperature. SVP is independent of atmospheric pressure and ambient volume; it depends solely on the chemical structure of the agent and the ambient temperature.
• Boiling Point ($T_b$): The temperature at which the saturated vapour pressure of the liquid equals the surrounding ambient atmospheric pressure. When ambient pressure decreases (e.g., at high altitude), boiling point decreases.
• Latent Heat of Vaporization: The energy (calories or joules) required to convert 1 gram of liquid into vapour at constant temperature. As liquid vaporizes inside a vaporizer, it absorbs heat from the remaining liquid and surrounding metal, dropping the liquid temperature and lowering the SVP unless compensated thermally.

Vaporizer Engineering Comparison:

Variable-Bypass Vaporizers (Sevoflurane, Isoflurane)   Tec 6 Heated Vaporizer (Desflurane)
- Fresh gas splits: bypass vs vaporizing chamber       - No splitting of fresh gas flow
- Temperature compensation: bimetallic strip           - Electrically heated to 39°C
- Agent-specific keyed filler collars                  - Pressurized to 2 atm (1500 mmHg)
- Relies on ambient vapor pressure                     - Pure desflurane vapor injected into FGF

The Desflurane Vaporizer Challenge: The Tec 6 Injector

Desflurane's boiling point (22.8°C at 1 atm) is remarkably close to standard ambient operating theatre temperatures (20-22°C). In an unheated variable-bypass vaporizer, slight environmental temperature elevations would cause desflurane to boil uncontrollably, producing massive cooling from the latent heat of vaporization, erratic vapour output, and potentially lethal anesthetic overdoses.

To overcome this, the Datex-Ohmeda Tec 6 (and Dräger D-Vapor) vaporizer is designed as an electrically heated, pressurized, gas-injection device:

1. It heats the desflurane sump to a thermostatically controlled 39°C, generating a constant internal saturated vapour pressure of approximately 2 atmospheres (~1500 mmHg / 200 kPa).
2. Fresh gas flow does not enter the desflurane chamber. Instead, fresh gas flows through a fixed resistance where a differential pressure transducer measures incoming gas flow rate.
3. A microprocessor-controlled precision throttling valve modulates the injection of pure desflurane vapour directly into the fresh gas stream proportional to the dialed concentration and fresh gas flow.

Clinical Trap at Altitude: Variable-bypass vaporizers (sevoflurane, isoflurane) deliver a constant partial pressure of agent regardless of altitude; because atmospheric pressure is lower at high altitude, the delivered percentage increases, maintaining clinical depth. In contrast, the Tec 6 vaporizer injects a fixed percentage (volume fraction) of desflurane. At high altitude, where total ambient pressure is reduced, the delivered partial pressure of desflurane is significantly lower than dialed, resulting in unintended light anaesthesia unless the dialed concentration is mathematically increased ($\text{Dialed } \% = \frac{\text{Desired } \% \times 760\text{ mmHg}}{\text{Ambient Pressure}}$).

---

2. Partition Coefficients and the Meyer-Overton Correlation

A partition coefficient ($\lambda$) is the distribution ratio of an anaesthetic between two immiscible phases at thermodynamic equilibrium (when the partial pressures in both phases are identical).

$\lambda_{A/B} = \frac{\text{Concentration in Phase A}}{\text{Concentration in Phase B}} \quad \text{at equal partial pressure}$

The Meyer-Overton Hypothesis and Lipid Solubility

The Meyer-Overton hypothesis states that the anaesthetic potency of an inhalational agent correlates directly with its lipid solubility, as quantified by its oil-gas partition coefficient ($\lambda_{o/g}$): $\text{MAC} \times \lambda_{o/g} \approx \text{Constant} \approx 1.3\text{ (MAC expressed in atmospheres)}$

• Agents with high oil-gas solubility (e.g., halothane $\lambda_{o/g} = 224$, isoflurane $\lambda_{o/g} = 98$) require very few molecules in the gas phase to achieve clinical immobility (low MAC: halothane 0.75%, isoflurane 1.15%).
• Conversely, agents with low lipid solubility (e.g., desflurane $\lambda_{o/g} = 19$, nitrous oxide $\lambda_{o/g} = 1.4$) have very high MAC values (desflurane 6.0%, $N_2O$ 104%).
• Modern Molecular Reality: Anaesthetics do not produce immobility through non-specific physical expansion of membrane lipids (the historic "critical volume hypothesis"). Instead, the Meyer-Overton correlation reflects binding to specific hydrophobic cavities and amino acid pockets on ion channel proteins ($GABA_A$ receptors, two-pore domain potassium channels like TREK and TASK, glycine receptors, and NMDA receptors).

---

3. Speed of Induction and Wash-In Dynamics: The $F_A/F_I$ Ratio

General anaesthesia depth is governed strictly by the partial pressure of anaesthetic in brain tissue ($P_{\text{brain}}$). Inhalational agents reach the brain across a continuous cascade of partial pressure gradients: $\text{Circuit Vapour } (P_I) \longrightarrow \text{Alveolar Gas } (P_A) \rightleftharpoons \text{Arterial Blood } (P_a) \rightleftharpoons \text{Brain Tissue } (P_{\text{brain}})$

Because arterial blood leaving pulmonary capillaries rapidly achieves partial pressure equilibrium with alveolar gas ($P_a \approx P_A$), and cerebral capillary blood equilibrates rapidly with brain tissue ($P_a \approx P_{\text{brain}}$), the rate of rise of alveolar concentration ($F_A$) toward inspired concentration ($F_I$)—the $F_A/F_I$ wash-in curve—is the universal determinant of induction speed.

FA / FI Ratio
1.0+============================================ N2O (0.47) & Desflurane (0.42)
   |                     ....................... Sevoflurane (0.65)
0.8|               .....'
   |          ...''
0.6|      ..''
   |    .'                                       Isoflurane (1.40)
0.4|  .'
   | /                                           Halothane (2.40)
0.2|/__________________________________________
  0+-------------------------------------------->
   0     2     4     6     8    10    12    14    16   Time (Minutes)

Physiological Determinants Governing the $F_A/F_I$ Ratio

Alveolar concentration represents a dynamic balance between delivery (input into alveoli via ventilation) and uptake (removal from alveoli into pulmonary capillary blood): $\text{Uptake} = \lambda_{b/g} \times \dot{Q} \times (P_A - P_v)$ where $\lambda_{b/g}$ is blood-gas solubility, $\dot{Q}$ is cardiac output, and $(P_A - P_v)$ is the alveolar-to-mixed venous partial pressure gradient.

1. Blood-Gas Partition Coefficient ($\lambda_{b/g}$):
   • Blood acts as a pharmacological reservoir or "sponge".
   • Highly soluble agents (halothane 2.4, isoflurane 1.4) dissolve extensively into pulmonary blood. This rapid dissolution removes agent molecules from the gas phase, preventing the generation of gas partial pressure. Alveolar partial pressure ($P_A$) rises sluggishly, resulting in a slow $F_A/F_I$ rise and delayed induction.
   • Insoluble agents (desflurane 0.42, nitrous oxide 0.47, sevoflurane 0.65) have low blood capacity. Blood quickly saturates with minimal dissolved molecules, allowing $P_A$ to build rapidly. The $F_A/F_I$ curve rises steeply, producing rapid induction and emergence.
2. Alveolar Ventilation ($\dot{V}_A$):
   • Increased ventilation accelerates the delivery of fresh agent into the alveoli.
   • Hyperventilation has a profound accelerating effect on the $F_A/F_I$ rise of soluble agents (halothane, isoflurane), because pulmonary uptake is massive and can be offset by increased replenishment.
   • Hyperventilation has minimal impact on insoluble agents (desflurane, $N_2O$), whose $F_A/F_I$ ratio is already near ceiling.
3. Cardiac Output ($\dot{Q}$ / Pulmonary Capillary Flow):
   • Increased cardiac output exposes more blood per minute to alveolar gas, augmenting uptake and carrying agent away into systemic tissues. This lowers alveolar partial pressure, slowing the rise of $F_A/F_I$.
   • In low cardiac output states (e.g., hemorrhagic shock, severe heart failure), decreased pulmonary flow lowers uptake, precipitating an alarmingly rapid surge in $F_A/F_I$, predisposing the patient to accidental volatile overdose.
4. Alveolar-to-Venous Partial Pressure Gradient ($P_A - P_v$):
   • At induction, mixed venous blood contains no anaesthetic ($P_v = 0$), so $(P_A - P_v)$ is maximal, driving maximal uptake.
   • As the Vessel-Rich Group (VRG) tissues saturate and return drug via venous blood, $P_v$ rises. This narrows $(P_A - P_v)$, uptake decreases, and $F_A/F_I$ approaches 1.0.
5. Functional Residual Capacity (FRC):
   • The FRC acts as an initial mixing chamber that dilutes inspired gas. A smaller FRC (infants, pregnancy, morbid obesity) allows faster alveolar wash-in and faster induction.

---

4. Kinetic Interactions: The Concentration Effect and Second-Gas Effect

When inhalational anaesthetics are administered in high concentrations, physical gas interactions accelerate alveolar wash-in beyond standard ventilation kinetics.

The Concentration Effect

Applies when a gas is delivered at high inspired fractions (e.g., 50-70% nitrous oxide). It comprises two distinct mechanisms:

1. The Concentrating Effect: The rapid uptake of huge volumes of $N_2O$ (up to 1000 mL/min initially) from the alveoli into pulmonary blood reduces the total volume of remaining alveolar gas. The unabsorbed gas molecules are compressed into a smaller alveolar volume, increasing their fractional concentration.
2. Augmented Tracheal Inflow: The rapid shrinkage of alveolar gas volume creates a transient sub-atmospheric alveolar pressure, drawing an additional volume of fresh gas from the breathing circuit into the lungs during inspiration.

The Second-Gas Effect

The second-gas effect is the practical extension of the concentration effect when two gases are administered simultaneously:

• A high concentration of a rapidly absorbed primary gas (first gas, e.g., 70% $N_2O$) is administered alongside a low concentration of a potent volatile anaesthetic (second gas, e.g., 2% sevoflurane).
• The massive, rapid uptake of $N_2O$ shrinks alveolar volume and draws an extra volume of circuit gas containing sevoflurane and oxygen into the lungs.
• Consequently, the rate of rise of the second gas's alveolar concentration ($F_A/F_I$) is significantly accelerated, producing faster induction than if the volatile agent were delivered in oxygen alone.

---

5. Emergence Dynamics and Gas Cavity Expansion

Emergence Phase (Discontinuation of N2O):

Blood (High N2O tension)  ========> Alveoli (Rapid N2O flooding)
                                       |
                                       v
                          Dilutes Alveolar O2  --> Diffusion Hypoxia
                          Dilutes Alveolar CO2 --> Decreased Respiratory Drive
                          Rescue: 100% O2 for 5-10 minutes

Diffusion Hypoxia (The Fink Effect)

Upon cessation of nitrous oxide anaesthesia, the partial pressure gradient reverses dramatically. Because nitrous oxide is 34 times more soluble in blood than nitrogen, massive volumes of $N_2O$ diffuse out of pulmonary capillary blood into the alveoli (up to 1-2 L/min during the first 5 minutes), far faster than nitrogen can dissolve into blood.

This massive influx of $N_2O$ into the alveoli:

• Dilutes Alveolar Oxygen: Alveolar $P_A O_2$ drops precipitously, producing severe, acute arterial hypoxemia (diffusion hypoxia or the Fink effect).
• Dilutes Alveolar Carbon Dioxide: Alveolar $P_A CO_2$ falls, blunting medullary chemoreceptor drive and inducing central hypoventilation.
• Prevention: Always ventilate the patient with 100% $\text{O}_2$ for at least 5 to 10 minutes following the discontinuation of nitrous oxide.

Expansion of Closed Gas Cavities

Nitrous oxide's 34-fold greater blood solubility relative to nitrogen governs its behavior in gas-containing body spaces. When $N_2O$ enters blood, it diffuses into an air-filled cavity 34 times faster than nitrogen can diffuse out into blood:

• Compliant Cavities (Volume Expansion): In non-rigid structures, the space rapidly expands. A pneumothorax can double in size within 10 minutes and triple within 30 minutes when exposed to 75% $N_2O$. Obstructed bowel loops expand, compromising mucosal perfusion and impeding surgical closure.
• Non-Compliant Cavities (Pressure Elevation): In enclosed rigid spaces, volume cannot expand, so pressure surges precipitously:
  • Middle Ear: Middle ear pressure can exceed 50 cmH$_2$O, dislodging tympanic membrane grafts or ossicular prostheses.
  • Venous Air Embolism: Inadvertent vascular air bubbles expand exponentially, causing acute right ventricular outflow obstruction and cardiovascular collapse.
  • Intraocular Gas Bubbles: In patients who have received intraocular gas injections (sulfur hexafluoride [$SF_6$] or perfluoropropane [$C_3F_8$]) for retinal detachment repair, $N_2O$ diffuses into the globe, causing catastrophic intraocular hypertension and central retinal artery occlusion with irreversible blindness. $N_2O$ must be avoided until the gas has been absorbed: roughly 2 weeks after $SF_6$ and 6 to 8 weeks after $C_3F_8$; follow the ophthalmologist's instructions or the patient's warning wristband.